Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 13, 2016

Rivaroxaban Associated With Increased Bleeding Risks vs Dabigatran in Elderly Patients With Nonvalvular Atrial Fibrillation

JAMA Internal Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxabanfor Nonvalvular Atrial Fibrillation
JAMA Intern Med 2016 Oct 03;[EPub Ahead of Print], DJ Graham, ME Reichman, M Wernecke, YH Hsueh, R Izem, MR Southworth, Y Wei, J Liao, MR Goulding, K Mott, Y Chillarige, TE MaCurdy, C Worrall, JA Kelman

Further Reading